Herbal Medicine Market Revenue to Witness Robust Expansion throughout the Forecast Period 2022-2028

Global Herbal Medicine Market is expected to flourish at a CAGR of 5.88% while garnering a market value of USD 136024.26 Million by 2023, predicts Market Research Future (MRFR).

Herbal Medicine Market Overview

The Herbal Medicine Market Revenue is estimated to be valued at USD 1,29,689.3 million by 2023 and expected to grow at a CAGR of 5.88% during the forecast period. The growing prevalence of cancer and infectious diseases across the globe, improving healthcare infrastructure, and skilled professionals are driving the growth of hospital and retail pharmacies in the Herbal Medicine Market Revenue. The hospital & retail pharmacies segment accounted for the largest market share of 55.82% in 2017.

Various government organizations such as the National Institutes of Health (NIH) have increased the spending on the research of medicinal applications of various plants for the treatment of various chronic diseases such as cancer, arthritis, and many more. According to the National Centre for Biotechnology Information, the National Institutes of Health (NIH) spent USD 111,275,219 on all cannabinoid research in 2015. The increasing acceptance of herbal medicines globally and raising funds for their development are likely to support market growth.

Herbal medicines are used since ancient times for numerous health conditions. It is the oldest and most extensively used system of medicine in the world today. There are various kinds of herbal medicines and supplements used across the world. According to the National Center for Biotechnology Information, 2015, the World Health Organization (WTO), reported that around 70% to 80% of people globally rely on herbal sources for their treatment. Also, according to the American Botanical Council, September 2017, it was reported that in 2016, the sale of herbal supplements increased by 7.7% in the US. It was also estimated that consumers spending on herbal supplements increased to USD 7.452 billion in 2016. Thus, the increase in the demand for herbal products for healthcare purposes is likely to enhance this market during the forecast period. 

Request Free Sample Copy at:

https://www.marketresearchfuture.com/sample_request/3250

Segmentation

Global Herbal Medicine Market Revenue has been segmented on the basis of category, source, form, distribution channel, and region. On the basis of category, the market is divided into herbal pharmaceuticals, herbal dietary supplements, herbal functional foods, and herbal beauty products. The herbal pharmaceutical segment is growing owing to the increasing research and development on various herbs to find their medicinal properties, growing demand for natural medicines having fewer side-effects, and rising prevalence of chronic diseases such as diabetes, arthritis, cancer, sleep disorders, and digestive problems.

On the basis of form, the market has been divided into extracts, powders, capsules and tablets, syrups, and others.

On the basis of distribution channel, is segmented into hospital and retail pharmacies, e-commerce, and others. The hospital & retail pharmacies segment accounted for the largest market share in 2017. The growing prevalence of cancer and infectious diseases across the globe, improving healthcare infrastructure, and skilled professionals are driving the growth of hospital and retail pharmacies in the Herbal Medicine Market Revenue.

Herbal Medicine Market

Regional Analysis

Geographically, the global Herbal Medicine Market Revenue is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. Americas accounts for the second largest share in the global Herbal Medicine Market Revenue. It accounted for a considerable market share of 16.2% as of 2017. The use of herbal medicines is also growing in the US after conducting the first national study of alternative and complementary medicines used by Eisenberg et al. According to the National Center for Biotechnology Information 2017, it was reported that herbal supplements were majorly used for conditions such as cancer (43.1%), stroke (48.7%), and arthritis (43%) in the US. Such a high demand and preference for herbal products is likely to boost the market growth during the forecast period.

Europe is expected to account for the largest market share owing to extensive R&D for herbal medicine, increasing funding for research on medicinal plants, and growing preference for herbal drugs globally. On a regional basis, Europe is segmented into Western Europe and Eastern Europe. Western Europe is estimated to lead market growth during the forecast period. The increasing prevalence of chronic diseases and rising government support facilitate market growth within the region.

Asia-Pacific is expected to register a CAGR of 5.99% during the forecast period owing to the adoption of traditional medicines by pharmaceutical companies, researchers, and policymakers. On the other hand, the Middle East and Africa is expected to observe a slow growth due to less awareness and in-depth knowledge about herbal drugs in this region.

Key Findings of the Study:

  • Asia Pacific is estimated to be the fastest growing market during the forecast period due to rising geriatric population and extensive use of healthcare IT
  • Marrubium vulgare is the dominant type of medicinal plants for Herbal Medicine Market Revenue across all regional segments during the forecast period due to the increasing applications of Marrubium vulgare.
  • The hospital & retail pharmacies segment accounted for the largest market share in the distribution channel segment owing to the growing prevalence of cancer and infectious diseases across the globe, improving healthcare infrastructure, and skilled professionals.
  • Herbal pharmaceutical accounted for the largest market share of 55.18% in 2017. The herbal pharmaceutical segment is growing owing to the increasing research and development on various herbs to find their medicinal properties, growing demand for natural medicines having fewer side-effects, and rising prevalence of chronic diseases such as diabetes, arthritis, cancer, sleep disorders, and digestive problems.
  • Some of the players operating in the Herbal Medicine Market Revenue are Arkopharma, Bayer AG, BEOVITA, Hishimo Pharmaceuticals, Schaper & Brümmer, ZeinPharma Germany GmbH, Venus Pharma GmbH, Dasherb Corp, and Arizona Natural Products among other.

This research report provides the insights, on various levels of analyses such as industry analysis, market share analysis leading market players and their profiles. This report also helps in studying the target segments by providing views on emerging & high-growth segments and market conclusion. Together the market data comprise and discuss with the basic assessments on the competitive scenarios & strategies, of the Global Herbal Medicine Market Revenue, including the high-growth regions and their political, economic and technological environments. Furthermore, the project report also provides the views over the historical market values as well as, pricing and cost analysis of the same.

Browse Detailed TOC with COVID-19 Impact Analysis at:

https://www.marketresearchfuture.com/reports/herbal-medicine-market-3250

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com